TSC1 and TSC2 are the tumor-suppressor genes mutated in the tumor syndrome TSC (tuberous sclerosis complex) and their gene products form a complex (TSC1–TSC2) that integrates signals upstream of mTOR signaling pathway through its GAP activity towards the small G-protein Rheb [42]. Here, MTOR is linked to neoplastic syndrome.